Jiangxi Provincial Cancer Hospital
Clinical trials sponsored by Jiangxi Provincial Cancer Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Scientists investigate why some thyroid cancers resist radioactive iodine Results expected Jun 2027 (estimated)
- Can a common antiseptic spray stop radiation burns in cancer patients? Results expected Jun 2027 (estimated)
-
New drug combo aims to keep High-Risk nasopharyngeal cancer at bay
Disease control Recruiting nowThis phase 3 trial tests whether adding toripalimab (an immunotherapy) to capecitabine (a chemotherapy pill) as maintenance therapy works better than capecitabine alone for people with high-risk nasopharyngeal carcinoma. The study enrolls 264 adults aged 18-70 who have completed …
Phase 3 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for recurrent throat cancer: Radiation-Immunotherapy combo shows promise
Disease control Recruiting nowThis phase II trial tests a new approach for recurrent nasopharyngeal carcinoma (a type of throat cancer) that has come back after initial treatment and cannot be removed by surgery. The treatment combines a special radiation schedule (low and high doses) with an immunotherapy dr…
Phase 2 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a common antiseptic spray stop radiation burns in cancer patients?
Prevention Recruiting nowThis study tests whether a chlorhexidine spray can prevent severe skin reactions caused by radiation therapy in people with nasopharyngeal cancer. About 148 participants will use the spray or a placebo during their treatment. The goal is to see if the spray reduces the chance of …
Phase 3 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC